Wilson Pharmaceuticals’ stock has done very well in the market
during the last three years. It has risen from $35 to $60 per
share. The firm’s current statement of stockholders’ equity is as
follows:
|
|
|
Common stock (3 million shares issued at par value
of $10 per share) |
$ |
30,000,000 |
Paid-in capital in excess of par |
|
12,000,000 |
Retained earnings |
|
48,000,000 |
|
|
|
Net worth |
$ |
90,000,000 |
|
|
|
|
a-1. How many shares would be outstanding after
a two-for-one stock split? (Do not round intermediate
calculations. Input your answer in millions (e.g., $1.23 million
should be entered as "1.23").)
a-2. What would be its par value? (Do
not round intermediate calculations and round your answer to 2
decimal places.)
b-1. How many shares would be outstanding after
a three-for-one stock split? (Do not round intermediate
calculations. Input your answer in millions (e.g., $1.23 million
should be entered as "1.23").)
b-2 What would be its par value? (Do
not round intermediate calculations and round your answer to 2
decimal places.)
c. Assume that Wilson earned $12 million. What
would its earnings per share be before and after the two-for-one
stock split? After the three-for-one stock split? (Do not
round intermediate calculations and round your answers to 2 decimal
places.)
|
|
|
|
EPS before |
|
EPS after 2-for-1 split |
|
EPS after 3-for-1
split |
|
|
d. What would be the price per share after the
two-for-one stock split? After the three-for-one stock split?
(Assume that the price-earnings ratio of 15.00 stays the same.)
(Do not round intermediate calculations and round your
answers to 2 decimal places.)
|
|
|
|
Price after 2-for-1 split |
|
Price after 3-for-1
split |
|
|